EuroSIDA
at HIV in Glasgow
EuroSIDA was nicely
presented at the 11th International Congress on Drug
Therapy in HIV Infection in Glasgow in November 2012.
All the five abstracts submitted to the conference were
accepted as oral presentations:
1. Temporal Changes
and regional Differences in Treatment Uptake of
hepatitis C Therapy in EuroSIDA presentation
2.
Increase in acute HCV incidence across Europe presentation
3.
CD4 count and viral load specific rates of AIDS,
non-AIDS and deaths according to current ART use presentation
4.
Immuno-virological discordance is associated with higher
frequency of fatal and non-fatal AIDS and non-AIDS presentation
5.
Advanced chronic kidney disease, end-stage renal disease
and renal death in HIV-positive individuals in Europe presentation
EuroSIDA
Investigators meeting during
Glasgow
Thank you to all EuroSIDA
Investigators who participated at the Investigators
meeting on 14 November 2012 during the Glasgow
conference. Attached to this Newsletter, please find the
Minutes and the presentation from this meeting.
Update of EuroSIDA Study
Group
In EuroSIDA we are currently
updating the Study Group list. Attached to this
Newsletter, you will find the Study Group document.
Please check if the data regarding your EuroSIDA centre
is correct. If your centre data needs to be updated,
please contact Jorunn at jtv@cphiv.dk
EuroSIDA
Plasma samples
Plasma samples are
collected every 6th month as an essential part of the
EuroSIDA study. These plasma samples are increasingly
important for the study. EuroSIDA centres that do not
collect plasma samples will soon receive an e-mail where
the possibilities of starting collecting these samples
will be discussed. Please ensure that the collection of
plasma samples is mentions in your Ethical approval for
your centre´s participation in the EuroSIDA study.
Updated EuroSIDA
documents
he EuroSIDA Protocol has
recently been updated to version 2.0. This Protocol (and
an updated Manual of Operations) will be sent out with
the Follow up forms for dataset 37. Please file these
two study documents in your EuroSIDA Study Binder. For
some centres an updated Protocol may request an updated
Ethical approval, please check with your local Ethical
committee if this will be requested. Please note that
due to new EU regulations, it is now possible in many EU
countries to obtain a common ES approval for all centres
within the same country.
Latest
Publications
Predicting the short-term
risk of diabetes in HIV-positive patients: the Data
Collection on Adverse Events of Anti-HIV Drugs (D:A:D)
study. K Petoumenos, SW Worm, E Fontas, R Weber, S De
Wit, M Bruyand, P Reiss, W El-Sadr, A d'Arminio
Monforte, N Friis-Möller, JD Lundgren, MG Law on behalf
of the D:A:D Study Group. Journal of the International
AIDS Society 2012, 15:17426 article
Benchmarking
HIV health care: from individual patient care to health
care evaluation. An example from the EuroSIDA study. D
Podlekareva, J Reekie, A Mocroft, M Losso, A Rakhmanova,
E Bakowska, IA Karpov, J Lazarus, J Gatell, JD Lundgren,
O Kirk. BMC Infect Dis. 2012 Sep 25;12(1):229 article
In
Press:
3 Health care index score and
risk of death following TB diagnosis in HIV-positive
patients. DN Podlekareva, D Grint, FA Post, A Mocroft,
AM Panteleev, RF Miller, JM Miro, M Bruyand, H Furrer, V
Riekstina, E Girardi, MH Losso, JA Caylá, EA
Malashenkov, N Obel, AM Skrahina, JD Lundgren, O Kirk
and the HIV/TB study group.IJTLD In Press
CD4
count and viral load specific rates of AIDS, non-AIDS
and deaths according to current antiretroviral use. A
Mocroft, A Phillips, J Gatell, A Horban, B Ledergerber.
K Zilmer, D Jevtovic, F Maltez, O Kirk, J Lundgren.
AIDS. In press
The VACS Index: An internationally
generalizable risk index for mortality after one year of
antiretroviral therapy. JP Tate, AC Justice, MD Hughes,
F Bonnet, P Reiss, A Mocroft, J Nattermann, FC Lampe, HC
Bucher, TR Sterling, HM Crane, MM Kitahata, M May, J
Sterne. AIDS. 2012 Nov 6 [Epub ahead of
print].
Durability of first ART regimen and risk
factors for modification, interruption or death in
HIV-positive patients starting ART in Europe and N.
America 2002-2009. S Abgrall on behalf of the
Antiretroviral Therapy Cohort Collaboration (ART-CC).
AIDS. 2012 Nov 28 [Epub ahead of print].
Total
number of EuroSIDA publications as of December 2012: 171
|
Follow-up forms for
dataset 37
The FU forms for dataset 37
are currently being sent out to all EuroSIDA centres.
Deadline for returning the forms is 1st February 2013.
If you have questions to the shipment of the forms,
please contact Jette atmailto:jen@cphiv.dk
EuroSIDA
at CROI 2013
Two EuroSIDA abstracts have
been accepted as Posters for CROI in Atlanta in March
2013. More information regarding these presentations
will follow.
.tmp)
Season´s
Greetings
EuroSIDA wishes to thank
everybody for their great contribution to the study in
2012 and is looking forward to our collaboration in
2013. Happy Holidays to everybody!
Update from EuroCoord
Please
find the latest EuroCoord
newsletter
at www.eurocoord.net
.tmp) |